BridgeMD
New treatment option for Arthropathy Shoulder
Official title CORA-Q15: Continuous vs. Single-injection Interscalene Block on QoR-15 in Outpatient Rotator Cuff Surgery
ClinicalTrials.gov ID: NCT06754657
What this study is testing
- What it's testing
- The purpose of the study will be to compare the efficacy of single-injection interscalene block versus continuous interscalene block on the quality of recovery in patients undergoing outpatient arthroscopic rotator cuff repair surgery. The participants will: Be randomized to receive either a single-injection interscalene block or continuous infusion via an elastomeric pump.
- Phase 4: studies an already-approved treatment
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75
You may be able to join if
- Adults (≥18 years, \< 75 years) scheduled for elective outpatient arthroscopic rotator cuff repair surgery.
- Patients capable of managing a continuous outpatient regional analgesia system based on an interscalene block (eligibility criteria: able to...
- Willing and able to provide informed, written consent to participate in the study.
You likely can't join if
- History of chronic opioid use (\>3 months).
- Severe comorbidities (e.g., renal or hepatic failure, ASA classification of 3 or higher).
- Allergy to local anesthetics, dexamethasone, or the analgesic drugs used in the study.
- Patients with contraindications for peripheral nerve block.
The study team makes the final eligibility decision.
Where it's taking place
- Santiago, Chile
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Santiago, Chile. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.